Results 21 to 30 of about 74,627 (275)

Differential diagnosis between benign and malignant pleural effusion with dual-energy spectral CT. [PDF]

open access: yesPLoS ONE, 2018
To investigate the value of spectral CT in the differential diagnosis of benign from malignant pleural effusion.14 patients with benign pleural effusion and 15 patients with malignant pleural effusion underwent non-contrast spectral CT imaging.
Xirong Zhang   +7 more
doaj   +1 more source

Induction of CCL8/MCP-2 by mycobacteria through the activation of TLR2/PI3K/Akt signaling pathway. [PDF]

open access: yes, 2012
Pleural tuberculosis (TB), together with lymphatic TB, constitutes more than half of all extrapulmonary cases. Pleural effusions (PEs) in TB are representative of lymphocytic PEs which are dominated by T cells.
Chen, Jianxia   +14 more
core   +9 more sources

Diagnostic value of procalcitonin and C-reactive protein in differentiation between some benign and malignant pleural

open access: yesEgyptian Journal of Chest Disease and Tuberculosis, 2014
Pleural effusion is relatively common clinical condition that requires differential diagnosis. It is defined as collection of fluid in pleural space. Pleural effusion is often diagnostic dilemma for the physician.
Wafaa S. El-Shimy   +4 more
doaj   +1 more source

New biomarkers for the diagnosis of pleural effusion

open access: yesThe Egyptian Journal of Bronchology, 2022
Background Persistent undiagnosed effusion is present in approximately 15% of all causes of exudative effusion. Pleural effusion caused by immunoglobulin G4 (IgG4) is a new type of pleural effusion.
Raafat T. El-Sokkary   +3 more
doaj   +1 more source

Pleural Fluid Mesothelin as an Adjunct to the Diagnosis of Pleural Malignant Mesothelioma [PDF]

open access: yes, 2014
Rationale:. The diagnosis of pleural malignant mesothelioma (MM) by effusion cytology may be difficult and is currently controversial. Effusion mesothelin levels are increased in patients with MM but the clinical role of this test is uncertain ...
Creaney, Jenette   +6 more
core   +2 more sources

A clinical study of pleural effusion and its radiological, biochemical, bacteriological and cytological correlation

open access: yesJournal of Integrated Health Sciences, 2017
Introduction: Pleural effusion refers to excessive or abnormal accumulation of fluid in the pleural space. It is a commonly encountered medical problem caused by a variety of underlying pathological conditions.
N D Khamar   +3 more
doaj   +1 more source

Inducers of epithelial mesenchymal transition and cancer stem cells in malignant pleural effusions [PDF]

open access: yes, 2016
The Epithelial to Mesenchymal Transition (EMT) plays a role not only in tumor metastasis but also in tumor recurrence. This process is believed to be tightly linked to the presence of Cancer Stem Cells (CSCs) however, it is still not clear which ...
Cherubini, Emanuela   +5 more
core   +1 more source

C-reactive protein and serum amyloid A levels in discriminating malignant from non-malignant pleural effusion

open access: yesEgyptian Journal of Chest Disease and Tuberculosis, 2015
Introduction: Distinction between malignant and non-malignant pleural effusion is of great importance in the patient management. The aim: We examined the diagnostic value of C-reactive protein (CRP) and serum amyloid A (SAA) in distinguishing different ...
Hala Mohamed Shalaby Samaha   +3 more
doaj   +1 more source

Recurrence of malignant melanoma presenting as black-colored pyopneumothorax: a rare entity

open access: yesAnnals of Saudi Medicine, 2017
We report a 63-year-old patient with black-colored pus (pyopneumothorax) resulting from an infected pleural effusion associated with metastatic malignant melanoma of the skin.
Ganesh Patel   +4 more
doaj   +1 more source

Different Therapeutic Strategies in 2 Young Patients with Advanced ALK-Rearranged Lung Adenocarcinoma: “The Light at the End of the Tunnel”

open access: yesCase Reports in Oncology, 2021
Malignant pleural effusion represents a prognostic negative factor on survival conferring stage IV disease. The median of survival is 5 months and a 5-year survival of about 3%.
Umberto Caterino   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy